Institutional net inflow hit $7.27 billion in the latest quarter, with 380 buyers vs 306 sellers. Over 90 days, insider selling totaled only $8.54 million—negligible against institutional moves.

Confirmation

Continued institutional accumulation next quarter confirms the bullish outlook.

Invalidation Risk

A shift to net institutional distribution or a jump in insider selling invalidates the view.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

90d confidence

unique buyers

—

buy value

data as of 2026-07-16

12-Month Buy/Sell Activity

Mar 25

Feb 26

BuySell

操作	內部人	職稱	交易日	金額
賣出	Stephen Hoge	President	2026-07-15	$3.61M
賣出	Klinger Shannon Thyme	Chief Legal Officer	2026-03-02	$726K
賣出	Stephen Hoge	President	2026-02-23	$7.81M
賣出	AFEYAN NOUBAR	Director	2025-12-11	$703K
賣出	Hussain Abbas	Director	2025-12-09	$14K
賣出	Hussain Abbas	Director	2025-06-11	$9K
買入	Bancel Stephane	Chief Executive Officer	2025-03-03	$3.19M
買入	Bancel Stephane	Chief Executive Officer	2025-03-03	$1.81M

View all insider trades →

Form 144 Pre-Sale Notices

Filings (90d)

$4.58M

Total Est. Value

83K shares

Planned Shares

Last Filed 2026-06-18

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
SAGAN PAUL	Former Director	2026-06-18	26K shares	$1.66M
Hoge Stephen	Officer	2026-06-15	53K shares	$2.74M
Klinger Shannon Thyme	Officer	2026-06-04	3K shares	$174K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-08

2026-07-08

Moderna announced on July 6, 2026, that it appointed Mr. McDonnell as a Class II director, with a term running until the 2029 annual shareholder meeting. The company also reshuffled its board committees: David Rubenstein left the Audit Committee to join the Nominating and Corporate Governance Committee, while McDonnell took Rubenstein's place on the Audit Committee. This is a routine director appointment and committee reassignment.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding MODERNA INC (MRNA)?

Major stakeholders currently include FMR LLC ($2.3B), BlackRock, Inc. ($1.5B), Vanguard Capital Management LLC ($1.2B). Based on the latest 13F filings, there are a total of 747 tracked investment funds and institutions maintaining positions in MRNA.

What is the overall institutional sentiment toward MRNA recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $7.3B, driven by 380 managers accumulating shares while 306 reduced their exposure.

Which institutions have been selling or reducing their MRNA positions?

In the latest period, 217 funds trimmed their holdings, and 89 managers completely exited their positions. The aggregate reported sell value was $7.2B.

Are there any notable investors adding MRNA to their portfolios?

Yes, buying activity remains notable. 139 institutions opened new positions in {ticker}, and 241 existing holders added to their shares. The total reported buy value for the quarter amounted to $7.9B.